Clinical Trials

Below is a list of active clinical trials worldwide which involve patients with inherited bleeding disorders. The link from each study title will take you to ClinicalTrials.gov which gives you more information about the trial.
To see a list of trials for a particular bleeding disorder use the drop-down list below to select the condition you're interested in. A new window will open up with a list of trials for this condition only.

PRIOR Study (Pre-eclampsia Risk In Oocyte Recipients) Conditions: Pre-eclampsia; Oocyte Donation; Pre-Eclampsia; Complicating Pregnancy; Pre-Eclampsia; Mild; Pre-Eclampsia, Severe; Pre-eclampsia or Eclampsia With Pre-existing Hypertension; ART; Neonatal Morbidity; Neonatal Mortality; Placental Abruption; Gestational Diabetes; Preterm Labor; Post-partum Hemorrhage (PPH); Intrauterine Growth Restriction (IUGR); Hypertensive Disorders of Pregnancy Sponsors: Copenhagen University Hospital, Hvidovre; Ferring Pharmaceuticals; Gedeon Richter Ltd. Recruiting

Feasibility and Safety of Blood-Flow-Restriction Training in Patients With Hemophilia Conditions: Hemophilia Interventions: Device: Control; Device: BFR Exercise (50% of the LOP) while Leg Press Exercise (4 Sets, All out) Sponsors: University Hospital, Bonn Enrolling by invitation

Link Between Abnormal Bleeding and Coagulation Disorders in Noonan Syndromes Conditions: Noonan Syndrome Interventions: Other: Reuse of routine clinical and biological data Sponsors: University Hospital, Bordeaux Not yet recruiting

A Trial of TER-1754 in Patients With Hereditary Hemorrhagic Telangiectasia Conditions: Hereditary Hemorrhagic Telangiectasia (HHT) Interventions: Drug: TER-1754; Drug: Placebo; Drug: TER-1754 Sponsors: Terremoto Biosciences Inc. Not yet recruiting

Anakinra Pilot 2 - A Study to Optimise Dose and Route of Administration of Anakinra in Preterm Infants Conditions: Premature Infants; Very Premature Infants; Inflammation Interventions: Drug: Anakinra (Kineret®) Sponsors: Monash Medical Centre; Monash University; Hudson Institute of Medical Research; Liggins Institute; Starship Children's Hospital of New Zealand Recruiting

Oral Health Related Quality of Life of Children With Amelogenesis Imperfecta Conditions: Amelogenesis Imperfecta Interventions: Procedure: Veneers Sponsors: Istanbul University Active, not recruiting

Ruxolitinib-Enhanced Haplo HCT for Children and Young Adults With Sickle Cell Disease Conditions: Sickle Cell Disease; Hematopoetic Stem Cell Transplant; Haploidentical Hematopoietic Stem Cell Transplant; Haploidentical Stem Cell Transplantation; Graft Failure Interventions: Drug: Ruxolitinib Sponsors: University of Colorado, Denver; Children's Healthcare of Atlanta; Emory University; Incyte Corporation Not yet recruiting

Early Hydrocortisone Versus Regular Treatment in Shock in Extremely Preterm Neonates - an Open Randomized Controlled Trial Conditions: Shock; Preterm Birth Complication; Preterm Intraventricular Hemorrhage; Asphyxia Perinatal; Distress Respiratory Syndrome; Hyperglycaemia (Non Diabetic); Neonatal Sepsis, Early-Onset; Neonatal Sepsis, Late-Onset; NEC - Necrotizing Enterocolitis; Patent Ductus Arteriosus in Preterm Infants; Intestinal Perforation Interventions: Drug: Intravascular Hydrocortisone (stress dosage): 1 mg/k/dose each 8 hours for 5 days; Other: Vasoactive drug therapies Sponsors: Coordinación de Investigación en Salud, Mexico; Instituto Mexicano del Seguro Social Active, not recruiting

Balance Evaluation in Adult Hemophilia Conditions: Postural Balance Interventions: Diagnostic Test: Postural balance assessment Sponsors: Ayse Merve TAT Completed